Showing results (2241-2250 of 2,341) with videos related to
Sort By:
Pageof 235
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Arm swing as a potential new prodromal marker of Parkinson's diseaseAnat Mirelman, Hagar Bernad-Elazari, Avner Thaler, et al.The American Journal of Psychiatry|January 4, 2008
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validityKeith H Nuechterlein, Michael F Green, Robert S Kern, et al.The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.Proceedings of the National Academy of Sciences of the United States of America|December 9, 2024
Early human collective practices and symbolism in the Early Upper Paleolithic of Southwest AsiaOmry Barzilai, Ofer Marder, José-Miguel Tejero, et al.Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.Blood|April 7, 2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registryDimitrios Giannis, Steven L Allen, James Tsang, et al.Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 23, 2017
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestryAnnie J Lee, Yuanjia Wang, Roy N Alcalay, et al.The Journal of Clinical Investigation|July 19, 2013
β-globin gene transfer to human bone marrow for sickle cell diseaseZulema Romero, Fabrizia Urbinati, Sabine Geiger, et al.Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.Pageof 235